癌可癒 靜脈輸注濃縮液 20 毫克/毫升

País: Taiwan

Língua: chinês

Origem: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingredientes ativos:

IRINOTECAN HYDROCHLORIDE TRIHYDRATE

Disponível em:

永信藥品工業股份有限公司 台中市大甲區頂店里中山路一段1191號 (56065601)

Código ATC:

L01CE02

Forma farmacêutica:

注射劑

Composição:

IRINOTECAN HYDROCHLORIDE TRIHYDRATE (9200037710) MG

Unidades em pacote:

小瓶裝;;盒裝

Classe:

製　劑

Tipo de prescrição:

限由醫師使用

Fabricado por:

永信藥品工業股份有限公司台中幼獅廠 台中市大甲區日南里工九路２７號 TW

Área terapêutica:

irinotecan

Indicações terapêuticas:

晚期性大腸直腸癌之第一線治療藥物： 與5-FU及folinic acid合併，使用於未曾接受過化學治療之患者。 單獨使用於曾接受5-FU療程治療無效之患者。 與cetuximab併用，治療曾接受含irinotecan之細胞毒性療法治療失敗且具有上皮生長因子接受體(EGFR)表現型KRAS野生型轉移性大腸直腸癌患者。 與5-fluorouracil、folinic acid及bevacizumab合併治療，做為轉移性大腸癌或直腸癌患者的第一線治療藥物。 與capecitabine合併治療，做為轉移性大腸直腸癌患者的第一線治療藥物。 與5-fluorouracil、leucovorin及oxaliplatin合併治療(FOLFIRINOX)，做為轉移性胰臟癌之第一線治療藥物。

Resumo do produto:

有效日期: 2028/12/25; 英文品名: Innocan Conc. Solution for I.V. Infusion 20mg/ml

Data de autorização:

2008-12-25

Folheto informativo - Bula

®
mL
Irinotecan Hydrochloride Trihydrate
....................................................................................................................
20mg
SorbitolLactic AcidSodium HydroxideHydrochloric Acid
Water For Injection
●
5-FUfolinic acid
●
5-FU
●
cetuximabIrinotecan(EGFR)
KRAS
●
5-fluorouracil
folinic acid
bevacizumab
●
capecitabine
●
5-fluorouracil
leucovorin
oxaliplatin
(FOLFIRINOX)
Irinotecan
Irinotecan350mg/m
2
30
90
Irinotecan
5-fluorouracil (5-FU)
folinic acid (FA)
■
Irinotecan5-FU/FA
Irinotecan180mg/m
2
30-90folinic acid
5-fluorouracil
cetuximab
IrinotecanIrinotecanIrinotecan
cetuximab
1
bevacizumab
bevacizumab
capecitabine
capecitabine
FOLFIRINOXoxaliplatin(85mg/m
2
)2leucovorin(400mg/m
2
)2
leucovorin30Y
irinotecan(180mg/m
2
)90IV bolus
fluorouracil(400mg/m
2
)fluorouracil(2,400mg/m
2
)4626
NCI-CTC0
1
Irinotecan
Irinotecan
5-FU
12
Irinotecan
5-FU15-20%
■
4
3-4
2-44
■
3-4
Irinotecancetuximab
capecitabine65
capecitabine
capecitabine800mg/m
2
capecitabine
oxaliplatin
l-leucovorin
fluorouracil
(FOLFIRINOX
)
2
1,500/mm
3
75,000/mm
3
1
()
fluorouracil
1)
2)
CTCAE version 4.0
oxaliplatin 85mg/m
2
180mg/m
2
fluorouracil
2,400mg/m
2
Oxaliplatin
Fluorouracil
-1 65mg/m
2
150mg/m
2
1,800mg/m
2
-2 50mg/m
2
120mg/m
2
1,200mg/m
2
-3
Irinotecan
2
Irinotecan
(ULN)
3
50%
Irinotecan
■
1.5Irinotecan
350mg/m
2
■
1.5-3Irinotecan
200mg/m
2
■
3
Irinotecan
Irinotecan
Irinotecan
Irinotecan
■
■
■
■
3
■
■
WHO2
■
(ST. JOHN'S WORT)
■
CETUXIMABBEVACIZUMABCAPECITABINE
IRINOTECAN
IRINOTECAN
■
WHO2
■
IRINOTECAN
IRINOTECAN24
IRINOTECAN5
2
IRINOTECAN
IRINOTECAN
LOPERAMIDE
4MG2
2MG
12
LOPERAMIDE4812
500
MM
3
■
■
■
LOPERAMIDE48
LOPERAMIDE
NCI CTC
34
1.0MG/DL3
41.0MG/DL
IRINOTECAN
381,000
MM
3
3,000/MM
3
10
MM
3
FOLFIRINOX2
7.5
MM
3
3,000/MM
3
10
MM
3
FOLFIRINOX
2
7.5
MM
3
IRINOTECAN
1.5
3IRINOTECAN
3
IRINOTECANIRINOTECAN
ATROPINE SULPHATE
0.25MG
IRINOTECANIRINOTECAN
IRINOTECAN
IRINOTECAN
ATROPINE SULPHATE
IRINOTECAN
(COLONY
STIMULATING FACTORS)IRINOTECAN
IRINOTECAN
IRINOTECA